U.S. Biotech Stock News

CompoSecure announced its second quarter and six-month 2025 earnings, reporting a net loss of US$26.13 million for the quarter and US$4.63 million for the half-year, alongside a sharp drop in sales compared to the prior year. For both periods, the company moved from profitability to loss and experienced a significant decrease in basic and diluted earnings per share, marking a sharp year-over-year downturn in financial performance. Given these unexpected losses and reduced sales, we’ll assess...

Certainly! Here’s the revised article with em dashes removed and rephrased for clarity: So, you are thinking about what to do with MercadoLibre’s stock right now. Maybe you already own shares and are debating whether to hold or trim, or perhaps you are wondering if this is the right moment to jump in. Either way, MercadoLibre has likely caught your attention for good reason. Over the past year, the Latin American e-commerce leader has not only outperformed many of its peers but has also...

Trying to Decide What to Do With Thermo Fisher Scientific Stock? Let’s talk about where Thermo Fisher Scientific sits right now, especially if you’ve been weighing whether to buy, hold, or step back for a while. The stock price is fresh off some interesting moves. After dropping over 18% in the last year, TMO has posted a strong comeback in recent weeks, gaining nearly 24% over the past three months and 22% in the last 30 days. Even just in the last week, shares ticked up by over 2%. Clearly,...

Anyone keeping an eye on Cintas (CTAS) might be wondering what is behind its latest price shift. The stock has been treading water this week, moving just a hair higher, with no headline-making events pushing it either way. While there is not a flashy earnings surprise or big acquisition to dissect, sometimes the absence of drama is noteworthy on its own. For investors, a quiet price move like this can be a subtle nudge to pause and rethink whether the current valuation tells the whole...

Wondering What to Do With Pinterest Stock? Here's What You Need to Know If you have Pinterest stock on your watchlist or already in your portfolio, you are definitely not alone. Investors are watching closely as social media platforms compete for attention in a crowded online world, each striving to establish a unique niche. Pinterest has quietly but consistently rewarded its supporters, posting a 16% return year-to-date and over 68% in total returns over the last three years. However,...

If you are wrestling with what to do about Meta Platforms stock right now, you are definitely not alone. In an environment where tech giants seem to headline every market conversation, it is easy to wonder whether Meta's incredible journey has more room to run or if it's time for caution. Over just the last month, the stock has pushed nearly 5% higher, and if you zoom out to the last year, the gains swell to an impressive 40%. Even more staggering, anyone who held on for three years has now...

If you are considering what to do with Jabil stock, you are far from alone. The company has caught the attention of both growth seekers and value-oriented investors, thanks to its impressive performance and intriguing valuation story. Over the past year, Jabil’s stock price has skyrocketed by 88%, making it one of the standouts in its sector. Zoom out further, and the picture looks even better. The total return for shareholders over the last three and five years has been 231% and over 500%,...

Thinking about Dell Technologies stock? You are not alone. Whether you are deciding whether to add more to your position or just looking to understand why this company is such a hot topic, it is hard to ignore Dell’s recent momentum. Shares have bounced around a bit in the last month, dipping about 0.4%, but if you zoom out the picture gets a lot rosier. Over the past three months, Dell Technologies has surged nearly 15%, and over the last year, the stock is up roughly 17%. This does not even...

Belite Bio (NasdaqCM:BLTE) just delivered its second-quarter earnings, and while the company is still in the red, something has changed: the loss is shrinking. For the quarter ended June, the net loss came in at $9.49 million compared to $16.32 million a year ago, and losses per share followed suit. Investors have been watching closely for any sign the biotech’s cash burn is easing, and this result might attract some attention. It is not common to see such a significant improvement,...

Has Eli Lilly (LLY) just put itself back on your radar? The company’s share price has edged up slightly in recent sessions. A modest 0.3% one day pop sits alongside a 6.8% gain on the week. However, stepping back, it’s actually down nearly 7% this month, and more than 25% off highs from a year ago. For investors, those red numbers are hard to ignore, especially given Eli Lilly’s pivotal role in pharmaceuticals and its strong reputation for pipeline innovation. This movement comes against the...

NYSE:RSKD 1 Year Share Price vs Fair Value Explore Riskified's Fair Values from the Community and select yours...

Earlier this week, Edwards Lifesciences reported strong Q2 results, raised its 2025 guidance, and announced a US$500 million accelerated share repurchase agreement, building on over US$800 million in shares repurchased during 2025. Despite a legal setback affecting margins, the company sharpened its focus on heart valve therapies after divesting its critical care business, while highlighting robust financial health and ongoing innovation. With the company’s new share repurchase program...

With a price-to-earnings (or "P/E") ratio of 34.6x WD-40 Company ( NASDAQ:WDFC ) may be sending very bearish signals at...

On August 7, 2025, Seadrill Limited released updated full-year 2025 earnings guidance, projecting operating revenues between US$1.32 billion and US$1.38 billion, excluding US$50 million in reimbursable revenues. This earnings update provides clearer revenue expectations amid evolving market conditions and is a key indicator of Seadrill's near-term operational outlook. We'll review how Seadrill's updated 2025 revenue guidance may influence expectations of future growth and resilience in...

Thinking about whether to hold onto, buy, or move on from Keysight Technologies stock? You are not alone. Navigating the world of tech stocks can feel like a rollercoaster, and Keysight’s journey lately has certainly kept investors on their toes. Over the past year, the stock has essentially stayed flat, eking out a tiny 0.4% gain. However, if you look at a five-year period, the story appears much brighter, with a total return of 61.6%. On shorter timeframes, there have been some minor dips,...

Earlier this month, Solventum Corporation completed a US$648.12 million follow-on equity offering and filed a US$2.48 billion shelf registration, issuing over 34 million shares of common stock. This sizable capital raise signals a potential shift in Solventum's capital structure, opening the door to expanded financial flexibility and future growth initiatives. To understand how this equity offering could influence Solventum's growth outlook, we'll explore its impact on the company's...

If you own shares of General Electric or you are considering buying in, you are probably asking yourself if this stock has more room to run. Over the past several months, GE’s stock price has steadily climbed, up 15.7% over the last quarter and more than 58% year-to-date. That momentum has been driven by strong earnings, optimism about the company’s aerospace division, and some broader moves in the industrial sector. It is also fair to say that global factors, like China’s restriction of key...

President Donald Trump recently issued an executive order allowing 401(k) retirement plans to invest in digital assets, a move expected to attract more institutional investment into cryptocurrency-related firms like Riot Platforms. This regulatory development may accelerate mainstream acceptance of cryptocurrencies and increase capital flows to bitcoin mining companies positioned within the digital asset ecosystem. We'll explore how the opening of 401(k) plans to digital assets could impact...

Thinking about what to do next with Fair Isaac stock? You are not alone. Whether you have held FICO through its impressive run over the past five years or you are eyeing the recent pullback and wondering if it is time to act, the outlook feels less certain these days. The stock soared more than 200% over the last five years, outpacing broader markets by a wide margin, but recently, momentum has cooled. In the last 90 days, FICO slid about 21%, and year-to-date, shares are down roughly 33%...

If you have been tracking Colgate-Palmolive (CL), recent price movements might have you wondering what is really driving investor sentiment. With shares closing near $86, the stock has slipped about 5% so far this year, and nearly 15% over the past twelve months. There is no single headline causing the shift, which can be just as intriguing, especially if you are considering whether the market is sending a signal or just repricing expectations for this household products...

Fifth Third Bancorp recently opened its first financial center in Huntsville, Alabama, expanding its retail footprint into a twelfth state and signaling the company’s intent to build up to 15 locations across Alabama by 2028. Leveraging proprietary data analytics and technology-driven innovation, Fifth Third is aiming for significant deposit growth while tailoring its local approach to rapidly growing markets like Huntsville, one of the fastest-expanding cities in the United States. We'll...

Earlier this month, Sotera Health reported second quarter 2025 earnings, posting revenue of US$294.34 million, a year-over-year increase, alongside a slight decrease in quarterly net income and a net loss for the six-month period. Alongside the earnings report, the company raised its full-year 2025 revenue growth guidance, reflecting management's increased confidence in near-term business prospects despite recent profit pressure. We'll explore how the raised revenue outlook shapes Sotera...

Here is the revised article with em dashes replaced and formatting improved: If you are watching AutoZone’s stock and wondering what your next move should be, you are definitely not alone. The auto parts retailer has delivered steady gains, with shares up nearly 30% over the past year and an impressive 86% over three years. That kind of sustained growth tends to get investors’ attention, especially with AutoZone’s consistent revenue and income increases showing through in the numbers. But...

If you are weighing what to do with Autodesk stock, you are definitely not alone. Lately, investors have watched as Autodesk’s share price has climbed roughly 14.5% over the past year, despite some choppy stretches that included a gentle pullback in recent months. For context, the stock closed recently at $288.63, still well off many analysts’ price targets. This suggests a potential upside of almost 18% from here. Each blip and rebound seems to reflect fresh views on Autodesk’s long-term...